搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
on MSN
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
6 小时
on MSN
Moderna, Inc. (MRNA): Worst Performing NASDAQ Stock in 2024
We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...
1 天
美国西北大学起诉Moderna侵犯LNP专利
作者:黄莺美国Moderna公司的专利官司持续不断。一周前,2024年10月12日,葛兰素史克公司(GSK)向美国特拉华州地方法院起诉Moderna,指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...
2 天
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
2 天
葛兰素史克起诉Moderna侵犯mRNA专利的真实意图
作者:黄莺俗话说人红是非多。在新冠疫情期间,凭借mRNA疫苗大获成功的Moderna公司,从年营收只有几千万美元的公司,一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年,Moderna与美国国立卫生研究院的mRNA ...
2 天
Moderna股价触及52周低点55.65美元,市场环境变化
Moderna ...
Crain's Chicago Business
1 天
Moderna appropriated Northwestern research for COVID vaccine, lawsuit alleges
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...
2 天
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...
IPWatchdog
1 天
Northwestern University Sues Moderna Over Spikevax Vaccine
Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...
FiercePharma
3 天
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...
Zacks.com on MSN
3 天
Moderna Stock Falls 20% in a Month: Time to Sell or Hold?
Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point ...
2 天
Moderna (MRNA) Receives a Hold from Jefferies
Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈